Evidence map›Paper›PMID 37445454›Full record

ReviewJournal of clinical medicine2023

The Multifold Etiologies of Limbal Stem Cell Deficiency: A Comprehensive Review on the Etiologies and Additional Treatment Options for Limbal Stem Cell Deficiency.

Majid Moshirfar, Maliha Masud, Devon Hori Harvey, Carter Payne, Elayna Bruce, Yasmyne C Ronquillo, Philip C Hoopes

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Autologous blood in the management of ocular surface disorders.World journal of experimental medicine · 2024
    Review
  8. Article
  9. Diagnostic approach to limbal stem cell deficiency.Frontiers in ophthalmology · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Majid MoshirfarHoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA.ORCID 0000-0003-1024-6250
Maliha MasudSchool of Medicine, University of Nevada Reno, Reno, NV 89557, USA.
Devon Hori HarveyCollege of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-8921-1290
Carter PayneHoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA.
Elayna BruceMcGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.ORCID 0009-0003-2814-8736
Yasmyne C RonquilloHoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA.ORCID 0000-0002-8852-4380
Philip C HoopesHoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA.
Hoopes Vision · USThe Ohio State University · USThe University of Texas Health Science Center at Houston · USUniversity of Nevada, Reno · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the various ocular manifestations of limbal stem cell insufficiency, an awareness of the genetic, acquired, and immunological causes and associated additional treatments of limbal stem cell deficiency (LSCD) is essential for providers. We performed a comprehensive review of the literature on the various etiologies and specific therapies for LSCD. The resources utilized in this review included Medline (PubMed), Embase, and Google Scholar. All English-language articles and case reports published from November 1986 through to October 2022 were reviewed in this study. There were collectively 99 articles on these topics. No other exclusion criteria were applied. Depending on the etiology, ocular manifestations of limbal stem cell deficiency range from dry eye syndrome and redness to more severe outcomes, including corneal ulceration, ocular surface failure, and vision loss. Identifying the source of damage for LSCD is critical in the treatment process, given that therapy may extend beyond the scope of the standard protocol, including artificial tears, refractive surgery, and allogeneic stem cell transplants. This comprehensive review of the literature demonstrates the various genetic, acquired, and immunological causes of LSCD and the spectrum of supplemental therapies available.

Indexed as

aniridiacontact lens-induced LSCDdry eye syndromelimbal stem cell deficiencylimbal stem cellslimbal stem cell transplantationmeibomian gland dysfunctionocular burn-induced LSCDPalisades of Vogtxeroderma pigmentosum

Identifiers

PMID37445454
PMCPMC10342698
OpenAlexW4383047328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.